Peptide Price Finder

Home · Clinical trials

LL-37 clinical trials

ClinicalTrials.gov lists 5 registered trials of LL-37: 0 recruiting or about to, 0 running, 4 completed, 1 with results posted. The largest is Salivary TAS, TOS, LL-37 and Dental Status in Passive Smoking Children (180 people).

5registered trials

0recruiting now

0running

4completed

0in phase 3

1with results posted

Completed: 4Status unknown: 15trials
  • Completed 4
  • Status unknown 1

Where LL-37 is in testing

Registered trials by phase. Phase 3 trials are the large ones that decide approval.

0Early phase 1First doses in people
0Phase 1Safety and dosing
2Phase 2Does it work?
0Phase 3Large confirmatory trials
0Phase 4After approval
3Not phasedObservational and other

Timeline

Each bar runs from a trial's start to its planned end; faded bars have no end date. Click a bar to open the trial.

20122014201620182020202220242026Peri-implant Vitamin D and Cathelicidin (LL-37) Levels · Completed · No phase · 33 people · 2021-04-01 to 2021-12-01Efficacy of LL-37 Cream on Bacteria Colonization, Inflammation Response and Healing Rate of Diabetic Foot Ulcers · Status unknown · Phase 2 · 40 people · 2019-10 to 2019-12Salivary TAS, TOS, LL-37 and Dental Status in Passive Smoking Children · Completed · No phase · 180 people · 2016-11-16 to 2018-04-15Intratumoral Injections of LL37 for Melanoma · Completed · Phase 1, Phase 2 · 4 people · 2015-07-08 to 2020-11-24Effects of Smoking and Vitamin D3 on the Levels of Human Cathelicidin Peptide LL-37 · Completed · No phase · 60 people · 2011-12 to 2012-07
RecruitingRunningCompletedStopped or withdrawnStatus unknownToday

Completed 4

Intratumoral Injections of LL37 for Melanoma

CompletedPhase 1, Phase 24 peopleM.D. Anderson Cancer Center2015-07-08 → 2020-11-24🇺🇸 United StatesResults posted

Studying: Melanoma · NCT02225366

About this trial

The goal of this clinical research study is to find the appropriate dose of LL37 that can be given to patients with melanoma. Researchers also want to learn if LL37 can stimulate the immune system to help control the disease.

Salivary TAS, TOS, LL-37 and Dental Status in Passive Smoking Children

Completed180 peopleMerve Erkmen Almaz2016-11-16 → 2018-04-15

Studying: Passive Smoking, Oxidative Stress, Dental Caries, Children · NCT04292548

About this trial

The aim of the present study was to determine the effect of passive smoking on the levels of salivary TAS, TOS, LL-37 and dental status in children.In the study the parents of children were asked to fill out a complete survey about smoking habits. After filling out the questionnaire, according to the survey results, a total of 180 children were included to the study as follows; 90 children exposed to passive smoking, and 90 children in the control group (unexposed controls). Also demographic data were recorded (age, gender, parental education levels, child's tooth-brushing habit and child's da…

Effects of Smoking and Vitamin D3 on the Levels of Human Cathelicidin Peptide LL-37

Completed60 peopleGazi University2011-12 → 2012-07

Studying: Periodontitis · NCT03923218

About this trial

The aims of our study were 1) to evaluate levels of gingival crevicular fluid( GCF) human cathelicidin peptide LL-37 and serum vitamin D3 in smoker and non-smoker patients with chronic periodontitis(CP) 2) to determine whether any correlation between GCF LL-37 and vitamin D3 serum levels exist and 3) to asses the correlation between clinical parameters and biochemical markers

Peri-implant Vitamin D and Cathelicidin (LL-37) Levels

Completed33 peopleAltinbas University2021-04-01 → 2021-12-01🌐 Turkey (Türkiye)

Studying: Peri-Implantitis and Peri-implant Mucositis · NCT06867250

About this trial

This research aims to explore the influence of vitamin D on the body's defense system by examining its impact on specific proteins involved in immune response and inflammation in the soft tissues surrounding dental implants. Also aims to determine how vitamin D levels affect these proteins and their role in protecting peri-implant tissues from microbial infections and inflammation.

Status unknown 1

Efficacy of LL-37 Cream on Bacteria Colonization, Inflammation Response and Healing Rate of Diabetic Foot Ulcers

Unknown statusPhase 240 peopleRandomizedFakultas Kedokteran Universitas Indonesia2019-10 → 2019-12🇮🇩 Indonesia

Studying: Diabetic Foot Ulcer · NCT04098562

About this trial

Diabetic foot ulcer (DFU) is a common complication of diabetes with global prevalence of 6.3%. Treatment of diabetic foot ulcer (DFU) is challenging with disappointing outcome. Wound debridement, infection control, pressure relief and revascularization are main pillars of DFU management. Various substances and modalities are being investigated for their potential effects in treating DFU, one of which is LL-37. In this randomized, controlled trial, 40 patients with uncomplicated DFU will be enrolled. Patients are randomly assigned to undergo twice a week treatment with 0.5 mg/mL LL-37 cream (t…

Registered trials include ones that haven't published results yet. Trials are matched on the compound's name and code names (LL-37, cathelicidin) in the listed interventions.